Syneos Health to Present at the 38th Annual J.P. Morgan Healthcare Conference

January 3, 2020

MORRISVILLE, N.C., Jan. 03, 2020 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (Contract Commercial Organization), today announced that Chief Executive Officer Alistair Macdonald is scheduled to present at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco, CA, on Wednesday, January 15, 2020, at 8:00 a.m. PST.

A live webcast of the event, along with a link to the presentation materials and archived audio replay of the presentation, will be available on the Company’s Investor Relations website at investor.syneoshealth.com.

About Syneos Health
Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. We bring together approximately 24,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to life®, visit syneoshealth.com or subscribe to our podcast.

Contacts

Investor Relations:     Press/Media:
Ronnie Speight     Danielle DeForge
Senior Vice President, Investor Relations     Executive Director, External Communications
+1 919 745 2745     +1 202 210 5992
Investor.Relations@syneoshealth.com     danielle.deforge@syneoshealth.com 



Syneos Health_rgb_r.jpg

Source: Syneos Health, Inc.